Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Bhandari, Pradeep ^a   Bateman, Adrian C ^a   Mehta, Raj L ^a   Stacey, Bernard S F ^a   Johnson, Penny ^b   Cree, Ian A ^b   Di Nicolantonio, Federica ^b   Patel, Praful ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS SURGERY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CYCLOOXYGENASE 2; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 33745315686     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-134     Document Type: Article

References (34)

1. Blot WJ: Esophageal cancer trends and risk factors. Semin Oncol 1994, 21.403-10.
2. Smans M, Muir CS, Boyle P, Smans M, Muir CS, Boyle P, editors: Atlas of cancer mortality In the EEC. Lyon: International agency for research on cancer 1992.
3. Mathews HR, Waterhouse JAH, Powell J, McConkey CC, Robertson JE, Editors: Cancer of the oesophagus. In Clinical cancer monographs vol London: Macmillan; 1987.
4. Greenlee RT, Hill-Harmon MB, Murray T, Thun M: Cancer statistics, 2001. CA Cancer J Clin 2001, 51:15-36.
5. Thun MJ, Namboodiri MM, Calle EF, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993, 53(6):1322-7.
6. Hla T, Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 1992, 89(16):7384-8.
7. Vane J: Towards abetter Aspirin. Nature 1994, 367:215-6.
8. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D: Selective expression of mitogen inducible cyclooxygenase in macrophages stimulated with lipopolysacharide. J Biol Chem 1992, 267:25934-8.
9. Sakamoto C, Matsuda K, Nakano O, Konda Y, Matozaki T, Nishisaki H, Kasuga M: EGF stimulates both cyclooxygenase activity and cell proliferation in cultured guinea pig gastric mucus cells. J Gastroenterol 1994, 29(7):73-6.
10. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM: Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993, 268(12):9049-54.
11. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 1998, 115(2):297-306.
12. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN: Up-regulation of cyclooxygenase 2 gene expression In human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107(4):1183-8.
13. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M: Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997, 57:1276-1280.
14. Koga H, Sakisaka, S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, Harada M, Kusaba T, Tanaka M, Kimura R, Nakashima Y, Nakashima O, Kojiro M, Kurohiji T, Sata M: Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 1999, 29(3):688-96.
15. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999, 59(5):987-90.
16. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ: Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998, 58(14):2929-2934.
17. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM: Suppression of intestinal polyposis In Apc delta 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87(5):803-9.
18. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000, 342(26):1946-52.
19. Kawamori T, Rao CV, Seibert K, Reddy BS: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, againstcolo carcinogenesis. Cancer Res 1998, 58(3):409-12.
20. Hara A, Yoshiml N, Niwa M, Ino N, Mori H: Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn J Cancer Res 1997, 88(6):600-4.
21. Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, Hori M: Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab invest 1999, 79(12):1469-77.
22. Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M: Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 1998, 274:1061-1067.
23. Buskens CJ, Van Rees BP, Sivula A. Reitsma JB, Haglund C, Bosma PJ, Offerhaus GJ, van Lanschot JJ, Ristimaki A: Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinorna of the esophagus. Gastroenterology 2002, 122(7):1800-7.
24. Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y, Yano M, Inoue M, Matsuura N, Shiozaki H, Monden M: Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 2000, 6(4):1229-38.
25. Nozoe T, Ezaki T, Kabashima A, Baba H, Kabashima, A: Significance of immunohistochemical expression of COX-2 in squamous cell carcinoma of the esophagus. Am J Surg 2005, 189(1):110-5.
26. France M, Drew PA, Dodd T, Watson DI: Cyclo-oxygenase-2 expression in esophageal adenocarcinoma as a determinant of clinicaloutcome following esophagectomy. Dis Esophagus 2004, 17(2):136-40.
27. Kinsel LB, Szabo I, Greene GL, Konrath J, Leight GS, McCarty KS: Immunacytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Reseach 1989, 49(4):1052-6.
28. Bhandari P, Bateman AC, Mehta RL, Patel P: Mucosal expression of cylooxygenase isoforms 1 and 2 is increased with worsening damage to the gastric mucosa. Histopathology 2005, 46:280-86.
29. Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ: Selective inhibition of cylooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Research 2000, 60:5767-72.
30. Reddy BS, Rao CV, Seibert K: Evaluation of COX-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Research 1996, 56-4566-69.
31. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998, 93:705-16.
32. Dohadwala M, Batra RK, Luo J, Lin Y, Krysan K, Pold M, Sharma S, Dubinett SM: Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cox-2 dependent invasion. J Biol Chem 2002, 277(52):50828-33.
33. Tomozawa S. Nagawa H, Tsuno N, Hatano K, Osada T, Kitayama J, Sunami E, Nita ME, Ishihara S, Yano H, Tsuruo T, Shibata Y, Muto T: Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer 1999, 81:1274-79.
34. Lagorce C, Paraf F, Vidaud D, Couverlard A, Wendum D, Martin A. Flejou J-F: Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma. Histopatholog 2003, 2:457-65.